HEADER TRANSFERASE 08-SEP-10 3OS5 TITLE SET7/9-DNMT1 K142ME1 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTONE-LYSINE N-METHYLTRANSFERASE SETD7; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HISTONE H3-K4 METHYLTRANSFERASE SETD7, H3-K4-HMTASE SETD7, COMPND 5 SET DOMAIN-CONTAINING PROTEIN 7, SET7/9, LYSINE N-METHYLTRANSFERASE COMPND 6 7; COMPND 7 EC: 2.1.1.43; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: DNMT1; COMPND 11 CHAIN: B; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SETD7, KIAA1717, KMT7, SET7, SET9; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PXC408; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES KEYWDS EPIGENETIC MODIFICATION, SET DOMAIN, PROTEIN LYSINE KEYWDS 2 METHYLTRANSFERASE, DNMT1, LYSINE MONO-METHYLATION, K142, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.-O.ESTEVE,Y.CHANG,M.SAMARANAYAKE,A.K.UPADHYAY,J.R.HORTON, AUTHOR 2 G.R.FEEHERY,X.CHENG,S.PRADHAN REVDAT 3 06-SEP-23 3OS5 1 REMARK LINK REVDAT 2 19-JAN-11 3OS5 1 JRNL REVDAT 1 15-DEC-10 3OS5 0 JRNL AUTH P.O.ESTEVE,Y.CHANG,M.SAMARANAYAKE,A.K.UPADHYAY,J.R.HORTON, JRNL AUTH 2 G.R.FEEHERY,X.CHENG,S.PRADHAN JRNL TITL A METHYLATION AND PHOSPHORYLATION SWITCH BETWEEN AN ADJACENT JRNL TITL 2 LYSINE AND SERINE DETERMINES HUMAN DNMT1 STABILITY. JRNL REF NAT.STRUCT.MOL.BIOL. V. 18 42 2011 JRNL REFN ISSN 1545-9993 JRNL PMID 21151116 JRNL DOI 10.1038/NSMB.1939 REMARK 2 REMARK 2 RESOLUTION. 1.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.68 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 801382.480 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 28645 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1421 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.69 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.75 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2301 REMARK 3 BIN R VALUE (WORKING SET) : 0.2650 REMARK 3 BIN FREE R VALUE : 0.3090 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 135 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.027 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1959 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 117 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.13000 REMARK 3 B22 (A**2) : -0.10000 REMARK 3 B33 (A**2) : -4.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.13 REMARK 3 LOW RESOLUTION CUTOFF (A) : 35.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.18 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.990 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.310 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.160 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.220 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.170 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 53.76 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3OS5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-SEP-10. REMARK 100 THE DEPOSITION ID IS D_1000061504. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30160 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.690 REMARK 200 RESOLUTION RANGE LOW (A) : 31.680 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.69 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.60400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 3CBM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 40% PEG3350, 100 MM TRIS, PH 7.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 50.67950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.26750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 50.67950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 19.26750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 378 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 111 REMARK 465 ASP A 112 REMARK 465 ASN A 113 REMARK 465 ILE A 114 REMARK 465 ARG A 115 REMARK 465 GLN A 365 REMARK 465 LYS A 366 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 116 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 135 CG CD OE1 OE2 REMARK 470 ARG A 152 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 176 CG CD OE1 OE2 REMARK 470 GLU A 183 CG CD OE1 OE2 REMARK 470 ASN A 188 CG OD1 ND2 REMARK 470 GLU A 271 CG CD OE1 OE2 REMARK 470 SER A 340 OG REMARK 470 LYS A 344 CG CD CE NZ REMARK 470 SER A 345 OG REMARK 470 GLU A 351 CG CD OE1 OE2 REMARK 470 LYS A 358 CG CD CE NZ REMARK 470 THR A 363 OG1 CG2 REMARK 470 GLN A 364 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 152 -49.48 -138.44 REMARK 500 ASP A 194 51.69 -146.24 REMARK 500 THR A 197 -169.55 -124.70 REMARK 500 ASP A 270 -162.04 -162.30 REMARK 500 CYS A 288 17.49 -142.78 REMARK 500 LYS A 344 118.81 -172.18 REMARK 500 PRO B 138 -57.15 -121.18 REMARK 500 SER B 143 117.32 88.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 391 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 392 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 393 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 394 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 395 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH A 1501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3CBM RELATED DB: PDB REMARK 900 SET7/9-ER PEPTIDE COMPLEX STRUCTURE REMARK 900 RELATED ID: 3CBO RELATED DB: PDB REMARK 900 SET7/9-ER PEPTIDE COMPLEX STRUCTURE REMARK 900 RELATED ID: 3CBP RELATED DB: PDB REMARK 900 SET7/9-ER PEPTIDE COMPLEX STRUCTURE DBREF 3OS5 A 111 366 UNP Q8WTS6 SETD7_HUMAN 111 366 DBREF 3OS5 B 137 144 PDB 3OS5 3OS5 137 144 SEQRES 1 A 256 LYS ASP ASN ILE ARG HIS GLY VAL CYS TRP ILE TYR TYR SEQRES 2 A 256 PRO ASP GLY GLY SER LEU VAL GLY GLU VAL ASN GLU ASP SEQRES 3 A 256 GLY GLU MET THR GLY GLU LYS ILE ALA TYR VAL TYR PRO SEQRES 4 A 256 ASP GLU ARG THR ALA LEU TYR GLY LYS PHE ILE ASP GLY SEQRES 5 A 256 GLU MET ILE GLU GLY LYS LEU ALA THR LEU MET SER THR SEQRES 6 A 256 GLU GLU GLY ARG PRO HIS PHE GLU LEU MET PRO GLY ASN SEQRES 7 A 256 SER VAL TYR HIS PHE ASP LYS SER THR SER SER CYS ILE SEQRES 8 A 256 SER THR ASN ALA LEU LEU PRO ASP PRO TYR GLU SER GLU SEQRES 9 A 256 ARG VAL TYR VAL ALA GLU SER LEU ILE SER SER ALA GLY SEQRES 10 A 256 GLU GLY LEU PHE SER LYS VAL ALA VAL GLY PRO ASN THR SEQRES 11 A 256 VAL MET SER PHE TYR ASN GLY VAL ARG ILE THR HIS GLN SEQRES 12 A 256 GLU VAL ASP SER ARG ASP TRP ALA LEU ASN GLY ASN THR SEQRES 13 A 256 LEU SER LEU ASP GLU GLU THR VAL ILE ASP VAL PRO GLU SEQRES 14 A 256 PRO TYR ASN HIS VAL SER LYS TYR CYS ALA SER LEU GLY SEQRES 15 A 256 HIS LYS ALA ASN HIS SER PHE THR PRO ASN CYS ILE TYR SEQRES 16 A 256 ASP MET PHE VAL HIS PRO ARG PHE GLY PRO ILE LYS CYS SEQRES 17 A 256 ILE ARG THR LEU ARG ALA VAL GLU ALA ASP GLU GLU LEU SEQRES 18 A 256 THR VAL ALA TYR GLY TYR ASP HIS SER PRO PRO GLY LYS SEQRES 19 A 256 SER GLY PRO GLU ALA PRO GLU TRP TYR GLN VAL GLU LEU SEQRES 20 A 256 LYS ALA PHE GLN ALA THR GLN GLN LYS SEQRES 1 B 8 THR PRO ARG ARG SER MLZ SER ALA MODRES 3OS5 MLZ B 142 LYS N-METHYL-LYSINE HET MLZ B 142 10 HET BME A 500 4 HET EDO A 391 4 HET EDO A 392 4 HET EDO A 393 4 HET EDO A 394 4 HET EDO A 395 8 HET UNL A 400 8 HET SAH A1501 26 HETNAM MLZ N-METHYL-LYSINE HETNAM BME BETA-MERCAPTOETHANOL HETNAM EDO 1,2-ETHANEDIOL HETNAM UNL UNKNOWN LIGAND HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE HETSYN EDO ETHYLENE GLYCOL FORMUL 2 MLZ C7 H16 N2 O2 FORMUL 3 BME C2 H6 O S FORMUL 4 EDO 5(C2 H6 O2) FORMUL 10 SAH C14 H20 N6 O5 S FORMUL 11 HOH *117(H2 O) HELIX 1 1 ASP A 209 GLU A 214 1 6 HELIX 2 2 THR A 251 SER A 257 1 7 HELIX 3 3 ASP A 259 ASN A 263 5 5 HELIX 4 4 LEU A 291 ALA A 295 5 5 HELIX 5 5 PRO A 350 GLN A 364 1 15 SHEET 1 A 6 CYS A 119 TYR A 122 0 SHEET 2 A 6 SER A 128 GLY A 131 -1 O LEU A 129 N ILE A 121 SHEET 3 A 6 GLY A 141 VAL A 147 -1 O VAL A 147 N SER A 128 SHEET 4 A 6 THR A 153 ILE A 160 -1 O GLY A 157 N ILE A 144 SHEET 5 A 6 GLU A 163 GLU A 176 -1 O LYS A 168 N TYR A 156 SHEET 6 A 6 ARG A 179 LEU A 184 -1 O HIS A 181 N SER A 174 SHEET 1 B 6 CYS A 119 TYR A 122 0 SHEET 2 B 6 SER A 128 GLY A 131 -1 O LEU A 129 N ILE A 121 SHEET 3 B 6 GLY A 141 VAL A 147 -1 O VAL A 147 N SER A 128 SHEET 4 B 6 THR A 153 ILE A 160 -1 O GLY A 157 N ILE A 144 SHEET 5 B 6 GLU A 163 GLU A 176 -1 O LYS A 168 N TYR A 156 SHEET 6 B 6 VAL A 190 TYR A 191 -1 O TYR A 191 N GLY A 167 SHEET 1 C 4 VAL A 216 GLU A 220 0 SHEET 2 C 4 GLU A 228 SER A 232 -1 O GLY A 229 N ALA A 219 SHEET 3 C 4 GLU A 330 VAL A 333 -1 O LEU A 331 N LEU A 230 SHEET 4 C 4 ASN A 296 HIS A 297 1 N ASN A 296 O VAL A 333 SHEET 1 D 3 VAL A 241 TYR A 245 0 SHEET 2 D 3 GLY A 314 THR A 321 -1 O LYS A 317 N TYR A 245 SHEET 3 D 3 CYS A 303 HIS A 310 -1 N ASP A 306 O CYS A 318 SHEET 1 E 3 VAL A 248 ILE A 250 0 SHEET 2 E 3 VAL A 274 ASP A 276 -1 O VAL A 274 N ILE A 250 SHEET 3 E 3 LEU A 267 SER A 268 -1 N LEU A 267 O ILE A 275 LINK C SER B 141 N MLZ B 142 1555 1555 1.33 LINK C MLZ B 142 N SER B 143 1555 1555 1.34 CISPEP 1 GLU A 279 PRO A 280 0 0.09 SITE 1 AC1 5 ASP A 194 LYS A 195 CYS A 200 SER A 202 SITE 2 AC1 5 GLU A 272 SITE 1 AC2 6 HOH A 15 HOH A 50 THR A 300 PRO A 301 SITE 2 AC2 6 ASN A 302 ARG A 323 SITE 1 AC3 4 TYR A 217 GLU A 220 PHE A 231 HOH A 381 SITE 1 AC4 6 HOH A 74 GLU A 228 ASN A 282 HIS A 283 SITE 2 AC4 6 LYS A 294 SAH A1501 SITE 1 AC5 2 TRP A 120 TYR A 122 SITE 1 AC6 3 GLU A 163 ASP A 256 PRO B 138 SITE 1 AC7 16 HOH A 14 HOH A 36 HOH A 52 HOH A 74 SITE 2 AC7 16 ALA A 226 GLU A 228 ASN A 265 HIS A 293 SITE 3 AC7 16 LYS A 294 ASN A 296 HIS A 297 TYR A 335 SITE 4 AC7 16 TRP A 352 GLU A 356 EDO A 393 MLZ B 142 CRYST1 101.359 38.535 66.541 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009866 0.000000 0.000000 0.00000 SCALE2 0.000000 0.025950 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015028 0.00000